+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 2Years - 11Years
All Genders
ID07767253

Evaluating the Safety and Effectiveness of 611 Injection in Chinese Children Aged 2 to Under 12 Years with Moderate to Severe Atopic Dermatitis

Led by Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · Updated on 2026-10-09

246

Participants Needed

5

Research Sites

43 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the efficacy of the drug 611 in Chinese children aged 2 to under 12 years with moderate to severe atopic dermatitis AD. This Phase III study includes two parts Part A focuses on pharmacokinetics in children aged 2 to under 6 years, while Part B is a confirmatory trial for children aged 2 to under 12 years. The study aims to assess improvements in skin condition using specific severity indices and to monitor safety and immune responses. In Part A, children aged 2 to under 6 years participate in a 30-week study consisting of up to 6 weeks of screening, 18 weeks of treatment with 611, and 6 weeks of follow-up. Part B involves children aged 2 to under 12 years and lasts up to 60 weeks, including up to 6 weeks of screening, an 18-week double-blind treatment period comparing 611 to placebo, a 36-week maintenance treatment, and a 6-week follow-up. The drug is administered as a subcutaneous injection. Results from Part A guide enrollment for Part B. Participants will undergo regular assessments including skin severity scoring EASI and IGA, pruritus rating scales, vital signs, physical exams, electrocardiograms, and laboratory tests. Researchers will also measure drug concentration and immune markers. Safety is closely monitored throughout the study, which lasts up to 60 weeks depending on the part. Participants are expected to use a stable moisturizer regimen during the trial and comply with contraceptive measures if applicable.

CONDITIONS

Brief Title

Evaluation of 611 in Chinese Children With Moderate to Severe Atopic Dermatitis(AD)

Research Team

Q

Qinghong Zhou, Master

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here